Episurf Medical submits 510(k) application for Episealer® Patellofemoral System
Episurf Medical (NASDAQ: EPIS B) today announces that the company is now filing a 510(k) application to the US FDA for US market clearance for the Episealer® Patellofemoral System. The application is ready for filing and following certain administrative steps, it is expected that it is submitted within the next days. The application will undergo a review process. Episealer® Patellofemoral System is an implant system with two implants for treatment of chondral and osteochondral lesions in the knee joint. The system is based on Episurf Medical’s proprietary implant technology with